Market
First country to challenge US COVID-19 vaccine liability protections internationally by 2025?
2
Resolution / Starting Odds
European Union • 25%
China • 25%
India • 25%
Other • 25%
International news reports or official government statements
Story
HHS Extends COVID-19 Vaccine Liability Protections Through 2029, Following 40 Years of Immunity Under NCVIA
Dec 10, 2024, 04:58 PM
The U.S. Department of Health and Human Services (HHS) has announced an extension of liability protections for manufacturers and administrators of COVID-19 vaccines until 2029. This decision aims to safeguard against potential health emergencies in the future. Since the enactment of the National Childhood Vaccine Injury Act in 1986, vaccine manufacturers have had immunity from lawsuits related to vaccine injuries. Most routine vaccines have enjoyed similar protections for nearly 40 years, while vaccines developed for emergencies have had protections for 20 years. The extension of these protections has been largely uncontroversial, according to experts.
View original story
Similar markets
United Kingdom • 25%
Canada • 25%
No International Challenge • 25%
European Union • 25%
Mexico • 33%
United States • 33%
Canada • 33%
None • 1%
China • 33%
Neither • 34%
Russia • 33%
European Union • 25%
United States • 25%
Other • 25%
United Kingdom • 25%
Germany • 25%
Italy • 25%
Spain • 25%
France • 25%
France • 25%
Netherlands • 25%
Italy • 25%
None by deadline • 25%
Other • 25%
China • 25%
EU • 25%
USA • 25%
European Union • 25%
United States • 25%
Other • 25%
United Kingdom • 25%
European Union • 25%
Other • 25%
United States • 25%
Japan • 25%
United States • 25%
China • 25%
Both • 25%
Neither • 25%
France • 25%
India • 25%
United States • 25%
Other • 25%